Danguole Vaznaisiene

Prof. Dr. Danguole Vaznaisiene

orcid
ID Physician, Assoc. Prof., MD, PhD - Department of Infectio...

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2025 in Bone & Joint Open
Verified
Journal Article
Open access
PDF file
VAVolker Alt
Volker Alt
DSDominik Szymski
Dominik Szymski
MRMarkus Rupp
Markus Rupp
AFAndreas Fontalis
Andreas Fontalis
Danguole VaznaisieneDanguole Vaznaisiene
Danguole Vaznaisiene
NWNike Walter
Nike Walter
Aims: Periprosthetic joint infections (PJIs) pose significant challenges to patients and healthcare systems worldwide. The aim of this study was to estimate the health-economic burden of reimbursement payment in Europe for PJIs following primary hip and knee arthroplasty.Methods: The calculation was based on health-economic modelling using data on primary hip and knee arthroplasties for the year 2019 from the Statistical Office of the European Union (Eurostat) and published infection rates to estimate the total number of hip and knee PJIs in 30 European countries. Revision procedures were stratified into: 1) debridement, antibiotics, and implant retention (DAIR); 2) one-stage exchange; and 3) two-stage revision procedures. The cases were then multiplied by the respective healthcare system reimbursement payments. Payment data were acquired from a survey of 13 countries (Austria, Croatia, France, Germany, Italy, Lithuania, Netherlands, Norway, Portugal, Slovenia, Switzerland, Turkey, and the UK) and extrapolated for the remaining countries.Results: In 2019, a total of 2,048,778 primary total joint replacements were performed (total hip arthroplasty (THA) = 1,147,316 and total knee arthroplasty (TKA) = 901,462), with an estimated 20,416 cases of PJIs (11,131 hip and 9,285 knee) in Europe. This results in an estimated total reimbursement burden of €346,262,026 for European healthcare systems. The breakdown for hip PJI reimbursement was €197,230,953 (€9,751,962 for DAIR procedures, €45,135,894 for one-stage revisions, and €142,343,097 for two-stage revisions). For knee PJIs, the analysis yielded a total reimbursement of €149,031,073 (€9,335,075 for DAIR procedures, €48,058,479 for one-stage revisions, and €91,637,518 for two-stage revisions).Conclusion: This is the first study to evaluate the health-economic burden of PJIs in Europe, revealing a substantial impact on healthcare systems with an estimated case load of 20,414 cases and overall reimbursement of €346,262,026 for primary THAs and TKAs performed in 2019.Cite this article: Bone Jt Open 2025;6(3):298–311.

1 February 2013 in Orthopaedics & Traumatology: Surgery & Research
Verified
Journal Article
Closed access
Danguole VaznaisieneDanguole Vaznaisiene
Danguole Vaznaisiene
EBE. Beltrand
E. Beltrand
ALA.P. Laiskonis
A.P. Laiskonis
YYY. Yazdanpanah
Y. Yazdanpanah
HMH. Migaud
H. Migaud
ESE. Senneville
E. Senneville

1 December 2010 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Closed access
Danguole VaznaisieneDanguole Vaznaisiene
Danguole Vaznaisiene
NGN. Le Gouellec
N. Le Gouellec
FAF. Ajana
F. Ajana
NBN. Baclet
N. Baclet
JPJ. Poissy
J. Poissy
LLL. Legout
L. Legout

30 June 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
Danguole VaznaisieneDanguole Vaznaisiene
Danguole Vaznaisiene
RSRita Sulcaite
Rita Sulcaite
Astra VitkauskieneAstra Vitkauskiene
Astra Vitkauskiene
ASArturas Spucis
Arturas Spucis
ARAnatolijus Reingardas
Anatolijus Reingardas
Eric SennevilleEric Senneville
Eric Senneville
The purpose of this cohort study was to assess the incidence of positive cultures in section’s osseous slice biopsy (SOB) taken at the level of major limb amputation. In case of positive cultures we sought whether the microorganisms present in SOB could take origin from the primary infection site necessitating the amputation. The impact of diabetes on culture results was also investigated. This prospective cohort study, which aimed to confirm the results of the pilot study, analysed patients who underwent major limb amputation between 2012 and 2013 in three Lithuanian hospitals. SOBs at the amputation site (surgical bone biopsies) and percutaneous bone biopsies of the distal site were performed simultaneously during limb amputation. Tissue cultures were analysed by microbiologists, and species along with antibiograms were reported. Histopathological assessment and bacterial typing were also evaluated. A positive culture was defined as the identification of at least 1 bacteria not belonging to the skin flora, at least 2 bacteria belonging to the skin flora with the same antibiotic susceptibility profiles or the same bacteria belonging to the skin flora in two different sites. Fisher’s exact test and Student’s test were used to compare the populations and the microbiological results. The statistical significance level was set at P < 0.05. Sixty-nine patients (35 males/34 females), mean age 68.7 (S = 13.6) years, including 21 (30.4 %) with diabetes underwent the major limb amputation. Forty-five amputations (65.2 %) were done above the knee. In total, 207 SOBs and 207 percutaneous distal site biopsies were studied. SOB cultures were positive in 11 (15.9 %) cases. In 5 (45.5 %) cases the same microorganisms were identified in both SOB and distal biopsy cultures. No association between culture results and presence of diabetes was identified. Our results suggest that, independently of the diabetes status, foot infection may silently spread along the bone and can achieve the site of major limb amputation. Additional investigations aiming to confirm this hypothesis and to evaluate a prognostic value are in progress.

13 October 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
ITIveta Tiepelyte
Iveta Tiepelyte
TKTomas Kadusauskas
Tomas Kadusauskas
ASAurimas Sirka
Aurimas Sirka
rihard trebserihard trebse
rihard trebse
Jaime EstebanJaime Esteban
Jaime Esteban
Danguole VaznaisieneDanguole Vaznaisiene
Danguole Vaznaisiene
Background and Clinical Significance: Trichoderma is a rare cause of human fungal infections. These infections are often severe and can be life-threatening, involving various organs and tissues. Although Trichoderma is not commonly encountered in clinical practice, its ability to cause infections is particularly significant in immunocompromised patients. As a result, cases in which Trichoderma is identified in human specimens are not only uncommon but also pose complex diagnostic and therapeutic challenges for clinicians. Although it can be associated with various organs, its clinical significance in joints, especially in periprosthetic joint infections, remains unclear. Case Presentation: This case report presents a 63-year-old immunocompromised woman with a suspected periprosthetic joint infection caused by Trichoderma. After total hip arthroplasty and subsequent bacterial periprosthetic joint infection, Trichoderma was revealed from two intraoperative samples. Given the unusual pathogen and the patient’s immunosuppression, antifungal therapy with amphotericin B was initiated. However, due to severe intolerance, the antifungal treatment had to be discontinued shortly after initiation, and the patient continued under close monitoring. We closely monitored the patient’s clinical status and laboratory test results, continuously considering whether the findings represented contamination or true infection. The patient exhibited clinical and radiological stability, reinforcing the hypothesis of contamination rather than active infection. Conclusions: This case explores the rarity of Trichoderma periprosthetic joint infections, the diagnostic and treatment challenges, and the importance of multidisciplinary input in managing such uncommon and complex cases. Further studies are needed to clarify the pathogenic significance, optimal management, and long-term outcomes of Trichoderma in bone and joint infections.

1 April 2026 in JBJS Open Access
Verified
Journal Article
Open access
KOKarsten D. Ottink
Karsten D. Ottink
FOFlaminia Olearo
Flaminia Olearo
Danguole VaznaisieneDanguole Vaznaisiene
Danguole Vaznaisiene
TRTim Rolvien
Tim Rolvien
KSkaoual salma
kaoual salma
MWMarjan Wouthuyzen-Bakker
Marjan Wouthuyzen-Bakker
Background: Isolating the causative microorganism in patients with a periprosthetic joint infection (PJI) before revision surgery is critical to determine the right surgical and antibiotic strategy. A wide variety in concordance between p-SFC and intraoperative cultures is reported in the literature. The objective was to determine the incidence of discordance and analyze risk factors for discordance between a positive preoperative synovial culture and intraoperative cultures in revision arthroplasty for PJI. Method: An international multicenter retrospective observational cohort study was conducted including patients with septic total revision arthroplasty, between January 2020 and January 2024. Discordance and risk factors were analyzed. Results: Discordance was 36% (n = 647). Risk factors for discordance were center specific: OR 4.22 (95% confidence interval [CI] 2.97-5.99), the presence of a sinus tract: odds ratio (OR) 1.80 (95% CI 1.22-2.66), and the hip joint: OR 1.61 (95% CI 1.12-2.30). Conclusion: Discordance between positive preoperative synovial fluid culture and intraoperative cultures in revision arthroplasty is relatively high, center-specific, and less reliable in patients with hip arthroplasty and/or a sinus tract.